Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency
- 4 September 2007
- Vol. 25 (45), 7824-7831
- https://doi.org/10.1016/j.vaccine.2007.08.036
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- DNA Vaccines Encoding Ii-PADRE Generates Potent PADRE-specific CD4+ T-Cell Immune Responses and Enhances Vaccine PotencyMolecular Therapy, 2007
- Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsExpert Review of Vaccines, 2007
- Vaccinia virus preferentially infects and controls human and murine ovarian tumors in miceGene Therapy, 2006
- COOPERATION BETWEEN CD4+AND CD8+T CELLS: When, Where, and HowAnnual Review of Immunology, 2006
- Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitopeGene Therapy, 2005
- Vaccination to prevent and treat cervical cancerHuman Pathology, 2004
- DNA Vaccines: Immunology, Application, and OptimizationAnnual Review of Immunology, 2000
- DNA VACCINESAnnual Review of Immunology, 1997
- DNA–based immunization by in vivo transfection of dendritic cellsNature Medicine, 1996
- Bax-independent inhibition of apoptosis by Bcl-XLNature, 1996